Abstract
This month our featured article is on the RACING trial, which compares the efficacy and safety of combination therapy of ezetimibe and moderate-intensity statin with monotherapy of high-intensity statin in patients with ASCVD.
Full Article
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
ConfirmKim BK, Hong SJ, Lee YJ, et al.
Lancet
First published: July 30, 2022 DOI: 10.1016/S0140-6736(22)00916-3
This month our featured article is on the RACING trial, which compares the efficacy and safety of combination therapy of ezetimibe and moderate-intensity statin with monotherapy of high-intensity statin in patients with ASCVD.